Wellington Global Health Care Equity Fund USD D Ac |
Performance History | 31/03/2025 |
Growth of 1,000 (GBP) | Advanced Graph |
![]() | Fund | 2.8 | -0.5 | -0.9 | -1.6 | -4.7 |
![]() | +/-Cat | -6.7 | 4.2 | 2.3 | -2.6 | -3.1 |
![]() | +/-B’mrk | -15.5 | -6.3 | 1.7 | -4.3 | -6.7 |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 09/04/2025 | USD 41.09 | |
Day Change | 2.82% | |
Morningstar Category™ | Sector Equity Healthcare | |
ISIN | IE00B00LSD17 | |
Fund Size (Mil) 10/04/2025 | USD 1672.00 | |
Share Class Size (Mil) 09/04/2025 | USD 551.10 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 21/03/2025 | 1.98% |
Investment Objective: Wellington Global Health Care Equity Fund USD D Ac |
The investment objective of the Fund is to seek long-term total returns. The Investment Manager will actively manage the Fund, seeking to outperform the MSCI World Health Care Index (the "Index”) and achieve the objective, primarily through investment in the equity securities of health care companies worldwide. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Rebecca Sykes 30/06/2022 | ||
Inception Date 30/09/2006 |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World/Health Care NR USD | Morningstar Gbl Health TME NR USD |
Portfolio Profile for Wellington Global Health Care Equity Fund USD D Ac | 28/02/2025 |
|
|
Top 5 Holdings | Sector | % |
![]() | ![]() | 9.82 |
![]() | ![]() | 7.23 |
![]() | ![]() | 5.11 |
![]() | ![]() | 5.05 |
![]() | ![]() | 4.33 |
![]() | ||
![]() ![]() ![]() | ||
Wellington Global Health Care Equity Fund USD D Ac |
Growth Of 1000 (GBP) | 31/03/2025 |
|
Annual Returns (GBP) | 31/03/2025 | |||||||
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 31/03 | |
Price Return | 2.37 | 24.46 | 20.33 | 2.75 | -0.47 | -0.86 | -1.59 | -4.74 |
+/- Category | -0.32 | 7.44 | 2.86 | -6.68 | 4.20 | 2.26 | -2.56 | -3.12 |
+/- Category Index | - | - | - | -15.46 | -6.28 | 1.68 | -4.29 | -6.67 |
% Rank in Category | 58 | 8 | 30 | 77 | 43 | 39 | 77 | 80 |
Trailing Returns (GBP) | 09/04/2025 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 2.82 | 3.22 | 5.22 |
1 Week | -4.45 | 1.40 | 0.53 |
1 Month | -9.73 | 0.52 | -0.33 |
3 Months | -13.51 | -2.80 | -4.20 |
6 Months | -16.89 | -4.88 | -4.47 |
YTD | -10.21 | -2.31 | -4.20 |
1 Year | -14.38 | -4.19 | -6.70 |
3 Years Annualised | -4.10 | 0.68 | -2.59 |
5 Years Annualised | 1.91 | -1.60 | -3.63 |
10 Years Annualised | 5.22 | -0.05 | -1.46 |
Category: Sector Equity Healthcare | |||
Category Index: Morningstar Gbl Health TME NR USD |
Quarterly Returns (GBP) | 31/03/2025 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2025 | -4.74 | - | - | - |
2024 | 6.63 | 1.11 | -2.26 | -6.62 |
2023 | -5.86 | 2.51 | -1.32 | 4.11 |
2022 | -5.32 | -0.60 | 3.16 | 2.51 |
2021 | -4.01 | 7.39 | -1.29 | 0.98 |
2020 | -7.61 | 21.50 | 1.60 | 5.51 |
Morningstar Rating™(Relative to Category) | 31/03/2025 | ||||||||||||||||||||
| |||||||||||||||||||||
Category : Sector Equity Healthcare | Click here to see our Methodology |
Volatility Measurements | 31/03/2025 | ||||||||||
| |||||||||||
Modern Portfolio Statistics | 31/03/2025 | 31/03/2025 |
Standard Index | Best Fit Index | |
Morningstar Gbl Health TME NR USD | Morningstar Gbl Health TME NR USD | |
3-Yr Beta | 1.01 | 1.01 |
3-Yr Alpha | -3.46 | -3.46 |
Investment Style Details | 28/02/2025 | ||||||||||||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
Category: Sector Equity Healthcare |
Asset Allocation | 28/02/2025 |
|
World Regions | 28/02/2025 | ||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||
Category: Sector Equity Healthcare |
Sector Weightings | 28/02/2025 | ||||||
| |||||||
Category: Sector Equity Healthcare |
Top 10 Holdings | 28/02/2025 |
Portfolio NEW | |
Total Number of Equity Holdings | 86 |
Total Number of Bond Holdings | 0 |
Assets in Top 10 Holdings | 47.91 |
Name | Sector | Country | % of Assets | ||
![]() | ![]() | United States | 9.82 | ||
![]() | ![]() | United States | 7.23 | ||
![]() | ![]() | Denmark | 5.11 | ||
![]() | ![]() | United Kingdom | 5.05 | ||
![]() | ![]() | United States | 4.33 | ||
![]() | ![]() | United States | 3.73 | ||
![]() | ![]() | United States | 3.42 | ||
![]() | ![]() | United States | 3.33 | ||
![]() | ![]() | United States | 3.15 | ||
![]() | ![]() | United States | 2.75 | ||
![]() ![]() ![]() | |||||
Category: Sector Equity Healthcare | |||||
Management | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
|
![]() | |
Biography | |
Rebecca Sykes is a global industry analyst and portfolio manager at Wellington Management, specializing in pharmaceuticals. Her portfolio management responsibilities include a variety of health care investment vehicles, including a global health care hedge fund, an emerging markets health care fund, and several other long-only health care equity products. She joined Wellington Management in 2007 from Goldman, Sachs & Co. where she was an analyst in the Health Care Investment Banking Group. She earned both her BS and MBA from the Wharton School of the University of Pennsylvania. She holds the Chartered Financial Analyst designation and is a member of the CFA Institute. |
Fees and Expenses | ||||||||||||
|
Purchase Details | ||||||||
| ||||||||
|